FierceBiotech: Acticor’s blood thinner cuts hemorrhage risk in human study, could offer hope for acute stroke

April 2019. Widely prescribed blood thinners such as COX-1 inhibitor aspirin and P2Y12 antagonist Plavix have a common problem: By decreasing platelet aggregation, they also increase the risk of uncontrolled bleeding.

Read full article